Skip to main content

NIA COVID-19 Response

In this rapidly evolving crisis, NIA is taking steps to support research into COVID-19 and older adults, particularly why they may be more susceptible to the virus, how they can be protected and the social and economic effects of the pandemic on older adults.

In a paper in the New England Journal of Medicine, scientific leaders from the National Institutes of Health, including NIA Director Richard J. Hodes, set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease. NIH established the Rapid Acceleration of Diagnostics (RADx) program to respond to this critical need.

Check this page frequently for updates on NIA’s response to the COVID-19 pandemic.

NIA late applications policy for May-July 2020 COVID-19-affected grants

NIA published NOT-AG-20-033, which gives applicants whose proposals are reviewed by NIA an automatic two-week extension on their application submission in the months of May, June and July 2020.

NIA is Funding Aging Research into COVID-19

In April, NIA published a Notice of Special Interest (NOSI) on NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19), NOT-AG-20-022. Open to NIA, National Institute of Mental Health, and National Institute on Alcohol Abuse and Alcoholism grantees, the NOSI is designed to support administrative and revision supplements in aging biology, behavioral and social research, geriatrics and gerontology and neuroscience related to COVID-19. Learn more about the NOSI in this Inside NIA blog post.

COVID-19 Funding Opportunities from NIA
Number Title Release Date
NOT-AG-20-022

Notice of Special Interest (NOSI) on NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) 
Read Frequently Asked Questions about this NOSI.

May 1, 2021
PAR-20-234 NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) February 2, 2021

In addition to soliciting applications for administrative supplements, NIA has joined the following Notices, NOSIs, and FOAs originating with other NIH Institutes and Centers:

Number

Title

Participating Organizations

Release Date

RFA-OD-20-018 Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) OD, NHLBI, NHGRI, NIA, NIDCR, NIDA, NCATS, Common Fund, NCI August 6, 2020
RFA-OD-20-014 Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) OD, NIA, NIAAA, NICHD, NCCIH, NCI, NHLBI August 6, 2020
RFA-OD-20-019 Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) OD, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NINR, NIMHD, NLM, NCCIH, NCATS, OBSSR August 6, 2020
NOT-OD-20-152 Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool OD, NIA, NICHD, NIDCD, NIDCR, NINDS, NINR, ORWH August 6, 2020
RFA-OD-20-022 Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) OD, NIA, NICHD, NIDCD, NIDCR, NINDS, NINR, NLM, ORWH August 6, 2020
RFA-OD-20-017 Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) OD, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDCR, NIMHD, NLM, NCATS August 6, 2020
NOT-OD-20-144 Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative OD, NICHD, NCI, NCATS, NCCIH, NHLBI, NIAID, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINR, NIA, NIAAA, NIDCD, NIDA, NIMHD, NLM, ORWH, Office of Strategic Coordination (Common Fund) July 10, 2020
PAR-20-243 Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NIMHD, NCCIH, NCATS, ODP, OBSSR, ORWH, SGMRO June 26, 2020
PAR-20-237 Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) NIMHD, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NINR, NCCIH, NCATS, SGMRO, ODP, ORWH June 17, 2020
NOT-OD-20-119 Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH June 12, 2020
NOT-OD-20-120 Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH June 12, 2020
NOT-OD-20-121 Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, National Institute of Allergy and Infectious Diseases (NIAID), NIAMS, NICHD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, National Institute of Neurological Disorders and Stroke (NINDS), NINR, NLM, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH June 12, 2020
RFA-OD-20-013 Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) 
Pre-application webinars will be held June 26 and July 1 (NOT-OD-20-131)
OD, NIMHD, NIA, NEI, NHLBI, National Human Genome Research Institute (NHGRI), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute of Biomedical Imaging and Bioengineering (NIBIB), NICHD, NIDCD, NIDCR, NIDA, NIEHS, National Institute of General Medical Sciences (NIGMS), NIMH, NINR, National Library of Medicine (NLM), Fogarty International Center (FIC), NCCIH, NCATS, National Cancer Institute (NCI), SGMRO, Tribal Health Research Office (THRO), ODP, OBSSR, ORWH June 12, 2020
NOT-OD-20-118 Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency Office of the Director (OD) June 10, 2020
NOT-MD-20-022

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations

NIMHD, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NCCIH, NCATS, SGMRO, ODP, OBSSR, ORWH June 5, 2020
NOT-MH-20-053

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

NIMH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NINR, NIMHD, NCCIH, National Center for Advancing Translational Sciences (NCATS), Sexual and Gender Minority Research Office (SGMRO), OBSSR, ODP, Office of Research on Women's Health (ORWH) June 5, 2020
NOT-MH-20-058

Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional)

NIMH, National Eye Institute (NEI), NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NCCIH, ODP, OBSSR June 4, 2020
NOT-MD-20-023

Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

NIMHD, NIA, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Dental and Craniofacial Research (NIDCR), National Institute on Drug Abuse (NIDA), NIEHS, NIMH, National Institute of Nursing Research (NINR), NCCIH, Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP), OBSSR, ORWH June 3, 2020

NOT-OD-20-097

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences

NIH Office of Behavioral and Social Sciences Research (OBSSR), National Heart, Lung, and Blood Institute (NHLBI), NIA, NIAAA, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Environmental Health Sciences (NIEHS), NCCIH, National Cancer Institute (NCI)

April 13, 2020

NOT-AT-20-011

Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019

National Center for Complementary and Integrative Health (NCCIH), NIA, NIAAA

April 10, 2020

NOT-MD-20-019

Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities

NIMHD, NIA, NIMH, NIAAA, NINDS

April 9, 2020

NOT-MH-20-047

Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus

NIMH, NIA, National Institute of Minority Health and Health Disparities (NIMHD), NIAAA

April 9, 2020

NOT-AG-20-022

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

National Institute on Aging (NIA), National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

April 2, 2020

Support for COVID-19 Interruptions for Funded Researchers

The pandemic and associated closures at institutions around the world present significant challenges for funded researchers managing existing studies. NIA is working with NIH and other HHS colleagues to help ease this burden and provide guidance and policies to ensure research can continue as much as is safe during the pandemic and resume with minimal negative impact after this crisis is over. After visiting the OER Coronavirus webpage for the latest guidance from NIH, NIA grantees are encourage to contact their program officers with specific questions.